Integrity Alliance LLC. purchased a new stake in Kimberly-Clark Co. (NYSE:KMB - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 2,189 shares of the company's stock, valued at approximately $311,000.
Several other hedge funds also recently made changes to their positions in the stock. Elevate Capital Advisors LLC boosted its stake in Kimberly-Clark by 46.4% during the first quarter. Elevate Capital Advisors LLC now owns 12,444 shares of the company's stock valued at $1,770,000 after buying an additional 3,944 shares during the period. Citigroup Inc. lifted its stake in Kimberly-Clark by 86.8% during the first quarter. Citigroup Inc. now owns 509,585 shares of the company's stock worth $72,473,000 after purchasing an additional 236,733 shares during the last quarter. Unigestion Holding SA lifted its stake in Kimberly-Clark by 8.2% during the first quarter. Unigestion Holding SA now owns 127,623 shares of the company's stock worth $18,145,000 after purchasing an additional 9,643 shares during the last quarter. OVERSEA CHINESE BANKING Corp Ltd lifted its stake in Kimberly-Clark by 270.2% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 984,695 shares of the company's stock worth $140,043,000 after purchasing an additional 718,720 shares during the last quarter. Finally, Farmers Trust Co. lifted its stake in Kimberly-Clark by 108.6% during the first quarter. Farmers Trust Co. now owns 45,088 shares of the company's stock worth $6,412,000 after purchasing an additional 23,472 shares during the last quarter. 76.29% of the stock is currently owned by hedge funds and other institutional investors.
Kimberly-Clark Stock Down 2.0%
Kimberly-Clark stock traded down $2.52 during midday trading on Monday, reaching $125.47. The company's stock had a trading volume of 3,077,549 shares, compared to its average volume of 2,306,897. The stock's 50-day simple moving average is $130.21 and its 200-day simple moving average is $134.39. The company has a debt-to-equity ratio of 7.05, a current ratio of 0.80 and a quick ratio of 0.54. Kimberly-Clark Co. has a 52-week low of $124.10 and a 52-week high of $150.45. The stock has a market capitalization of $41.63 billion, a P/E ratio of 16.62, a PEG ratio of 4.46 and a beta of 0.32.
Kimberly-Clark (NYSE:KMB - Get Free Report) last released its quarterly earnings results on Friday, August 1st. The company reported $1.92 EPS for the quarter, beating analysts' consensus estimates of $1.67 by $0.25. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%.The company had revenue of $4.16 billion during the quarter, compared to analysts' expectations of $4.85 billion. During the same period last year, the business posted $1.96 earnings per share. The firm's revenue was down 1.6% compared to the same quarter last year. On average, sell-side analysts expect that Kimberly-Clark Co. will post 7.5 EPS for the current year.
Kimberly-Clark Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 2nd. Stockholders of record on Friday, September 5th will be paid a $1.26 dividend. This represents a $5.04 annualized dividend and a dividend yield of 4.0%. The ex-dividend date is Friday, September 5th. Kimberly-Clark's dividend payout ratio (DPR) is presently 69.42%.
Analyst Ratings Changes
Several research analysts have recently commented on KMB shares. JPMorgan Chase & Co. upgraded Kimberly-Clark from an "underweight" rating to a "neutral" rating and lifted their price objective for the stock from $125.00 to $138.00 in a report on Monday, August 4th. UBS Group dropped their price target on Kimberly-Clark from $146.00 to $139.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. Barclays upped their price objective on Kimberly-Clark from $134.00 to $139.00 and gave the company an "equal weight" rating in a research report on Monday, August 4th. Finally, Piper Sandler assumed coverage on Kimberly-Clark in a report on Friday, July 18th. They set an "overweight" rating and a $144.00 price target on the stock. Three analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $142.70.
View Our Latest Research Report on Kimberly-Clark
Kimberly-Clark Company Profile
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
See Also

Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.